Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market 2025–2029: Unveiling Growth Developments with the Latest Updates
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Present And Forecasted Size Of The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
The market size of contract development and manufacturing organizations (CDMO) for advanced therapy medicinal products has seen a significant escalation in the recent years. The market, which is projected to augment from $5.31 billion in 2024 to approximately $6.2 billion in 2025, will experience a compound annual growth rate (CAGR) of 16.7%. Factors contributing to this historic surge include an increase in ATMP clinical trials, heightened awareness and conviction in the scientific community regarding the advantages of advanced therapy, the existence of numerous ATMP CDMOs, intensified endeavors to create innovative therapies for diverse diseases, and government initiatives that promote growth in this sector.
Expectations indicate that the market size of advanced therapy medicinal products contract development and manufacturing organization (cdmo) will expand swiftly in the forthcoming years. By 2029, it is predicted to reach $11.12 billion, with a compound annual growth rate (CAGR) of 15.7%. Factors attributing to this growth during the forecast period include high investment from CDMOs, rising presence of new entrants in the cell and gene therapy (CGT) sector, increased funding and investments directed towards the development of cell and gene therapies, growth in pharmaceutical R&D expenditure, and a surge in the number of clinical trials for ATMPs. Key trends projected during the forecast period encompass advancements in AAV biomanufacturing facilities, expansion in cell and gene therapy manufacturing, technological progress in cell and gene therapy, an escalating requirement for access to advanced platforms and technologies, alongside integration of progressive technologies like CRISPR and next-generation sequencing for improved accuracy.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15719&type=smp
Which Market Dynamics Are Playing A Critical Role In The Growth Of The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
The anticipated growth of the advanced therapy medicinal products CDMO market is largely attributed to the rise in the number of clinical trials. These trials, performed on humans, assess the safety and effectiveness of various medical processes including drugs, remedial interventions, devices, and preventative measures. The surge in these trials is in response to the escalating demand for cutting-edge treatments and the increasing worldwide disease burden. As the application of advanced therapy medicinal products increases, so does the demand for CDMO manufacturing services. These services draw on expert knowledge and infrastructure to support the growing need. Data from clinical trials contribute to improving manufacturing, maintain scalability, and ensure constant quality to fulfill the extensive clinical and commercial demands. For example, the Association of the British Pharmaceutical Industry, a UK-based trade group, noted a minor increase of 4.3% in the total number of industry clinical trials launched in the UK annually, from 394 in 2021 to 411 in 2022. Hence, the growing number of clinical trials is fueling the development of the advanced therapy medicinal products CDMO market.
What Are The Key Segment Trends Observed In The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
The advanced therapy medicinal products contract development and manufacturing organization (cdmo)market covered in this report is segmented –
1) By Product: Gene Therapy; Cell Therapy; Tissue Engineered
2) By Phase: Phase I; Phase II; Phase III; Phase IV
3) By Indication: Oncology; Cardiology; Central Nervous System And Musculoskeletal; Infectious Disease; Dermatology; Endocrine, Metabolic, Genetic; Immunology And Inflammation; Ophthalmology; Hematology
Subsegments:
1) By Gene Therapy: Viral Vectors; Non-Viral Vectors; Dna Or Rna-Based Products
2) By Cell Therapy: Autologous Cell Therapy; Allogeneic Cell Therapy; Stem Cell Therapy
3) By Tissue Engineered: Skin Substitutes; Cartilage And Bone Tissue; Vascular Grafts And Organs
Which Disruptive Trends Are Driving Change Across The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
Leading companies in the advanced therapy medicinal products CDMO market are providing innovative cell therapy manufacturing solutions to resolve vital challenges in cell therapy manufacturing and expedite their partners’ development activities. These services, provided by contract development and manufacturing organizations, can range from the initial stages of preclinical development to late-stage clinical trials and eventual commercialization. For example, in January 2024, Pluristem Therapeutics Inc., a biotech firm based in Israel that converts cells into solutions, established PluriCDMO, a new business segment focused on cell therapy manufacturing. The division uses a patented bioreactor system for 3D cell multiplication, enabling the creation of a range of cell types, including but not limited to, stem cells, induced pluripotent stem cells, exosomes, and immune therapies. PluriCDMO aims to deliver high-quality, essential medicines to patients reliably, ensuring uniformity between different batches, scalability, and cost-effectiveness in the applications of good manufacturing practices.
Who Are The Leading Companies Driving The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
Major companies operating in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market are Thermo Fisher Scientific Inc., Merck KGaA, Resonac Corporation, Lonza Group AG, Catalent Inc., Charles River Laboratories International Inc., Recipharm AB, KBI Biopharma, Takara Bio Inc., Rentschler Biopharma SE, Ajinomoto Co. Inc., ElevateBio LLC, Fujifilm Diosynth Biotechnologies, Axplora Group GmbH, WuXi Advanced Therapies Inc., Celonic Group, Batavia Biosciences B.V., BioCentriq, Cytovance Biologics, Andelyn Biosciences, Genezen, AGC Biologics, ABL Manufacturing, Minaris Regenerative Medicine, Porton Advanced Solutions
Access The Complete Report Here:
Which Region Is Forecasted To Lead The Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market In The Coming Years?
North America was the largest region in the advanced therapy medicinal product contract development and manufacturing organization (CDMO) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=15719&type=smp
Browse Through More Reports Similar to the Global Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market 2025, By The Business Research Company
Advanced Therapeutics Pharmaceutical Outsourcing Global Market Report 2025
Advanced Ceramics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/advanced-ceramics-global-market-report
Advanced Biofuels Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/advanced-biofuels-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
